DRY NEEDLING VS. CUPPING THERAPY IN MPS
2026年6月30日 更新者：Fatma Nur BULDUK、Turkish League Against Rheumatism
COMPARISON OF THE EFFECTIVENESS OF DRY NEEDLING AND CUPPING THERAPY IN PATIENTS WITH MYOFASCIAL PAIN SYNDROME: A RANDOMIZED TRIAL
This study aimed to compare the effectiveness of dry needling and cupping therapy in patients diagnosed with myofascial pain syndrome involving the trapezius, supraspinatus, infraspinatus, and levator scapulae muscles.
Treatment efficacy was evaluated using the visual analog scale (VAS), the number of trigger points, the Likert satisfaction scale, and the multidimensional quality of life scale.
調査の概要
詳細な説明
This study evaluated the effectiveness of dry needling (DN) and cupping therapy in 92 patients with chronic myofascial pain syndrome. Participants were randomly divided into two groups: one receiving a 10-session cupping regimen and the other undergoing a three-session dry needling protocol, with both groups performing home-based exercises.
Results showed that both treatments significantly reduced pain and improved patient outcomes over three months. When compared directly, cupping therapy was more effective at reducing trigger points and improving overall quality of life. Conversely, dry needling resulted in higher levels of patient satisfaction. In conclusion, both methods are valuable tools for managing myofascial pain, and the choice of treatment may depend on whether the clinical priority is physical symptom relief or patient preference. Further research is recommended to better define the specific long-term applications of these therapies.
研究の種類
介入
入学 (実際)
92
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
-
Erzurum、トルコ（Türkiye）、25240
- Ataturk University
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
いいえ
説明
Inclusion Criteria:
- Back pain lasting more than three months
- At least one palpable myofascial TN in the trapezius, supraspinatus, infraspinatus, and/or levator scapulae muscles
- Written informed consent
Exclusion Criteria:
- Prior dry needling treatment
- Prior cupping therapy
- Severe cognitive dysfunction
- Spinal fracture
- Infection
- Malignancy
- Ankylosing spondylitis
- Central nervous system injury
- Psychiatric disorder
- Diseases causing tissue degeneration
- Conditions associated with spasticity or cerebrovascular disease
- Cervical radiculopathy due to structural abnormalities
- Muscle or tendon injuries of the shoulder or neck
- Fibromyalgia or other conditions presenting with symptoms similar to myofascial pain syndrome
- Use of anticoagulant or antiplatelet therapy
- Thrombocytopenia or hemorrhagic disorders
- A history of surgery or blood donation within the previous three months
- Pregnancy
- Breastfeeding
- Presence of renal, hepatic, or severe cardiovascular disease
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Cupping therapy arm
Dry cupping was conducted 3 times per week for 9 sessions, followed by one session of wet cupping at the tenth session.
|
In the tenth session, wet cupping was performed directly over the patients' TNs.
In addition to the TNs, wet cupping was also applied at the Dazhui DU-14 point in all patients.
Before initiating the procedure, the treatment area was disinfected with alcohol.
Sterile single-use cups numbered 5 and 6 were applied to the treatment area.
After 3 to 5 minutes, the cups were removed one at a time.
After the area was cleaned, a No. 15 scalpel blade was used to make shallow vertical cuts at the cupping site.
Afterward, the cups were returned to the same places.
The procedure was performed three times without making any new cuts.
The blood was drained, and the cups were put back on.
The entire procedure lasted approximately 20 min.
The cups were removed at the end of the procedure, and the area that had been treated was cleaned and covered properly.
|
|
アクティブコンパレータ：Dry needling arm
Participants in this arm received three sessions of dry needling, administered once per week.
|
Needling was performed while the TNs in the levator scapulae, supraspinatus, and upper part of the trapezius muscles were sitting.
Patients were placed in the prone position for the middle and lower parts of the trapezius and infraspinatus muscles.
To increase the accuracy of localization and minimize the risk of injury to nearby structures, needling was performed under ultrasound guidance.
We used the Esaote MyLab 60 ultrasound machine that we have in our clinic for this.
Standard single-use sterile acupuncture needles (0.25 mm × 25 mm) were used.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Visual analog scale
時間枠：From enrollment to the end of the first month
|
The VAS score was used to measure pain intensity in each patient.
Patients were told to rate their pain on a 10-cm horizontal line for the VAS test.
A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
|
From enrollment to the end of the first month
|
|
Trigger points count
時間枠：From enrollment to the end of the first month
|
Trigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
|
From enrollment to the end of the first month
|
|
Multidimensional quality of life score
時間枠：From enrollment to the end of the first month
|
The multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items.
The overall score is obtained by summing the responses to all the items.
Each item is given a score from 1 to 7, with a total score of 35 to 245.
Higher scores indicate better functional status.
|
From enrollment to the end of the first month
|
|
Likert satisfaction scale
時間枠：From enrollment to the end of the first month
|
Patient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.
|
From enrollment to the end of the first month
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Visual analog scale
時間枠：From enrollment to the end of the third month
|
The VAS score was used to measure pain intensity in each patient.
Patients were told to rate their pain on a 10-cm horizontal line for the VAS test.
A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
|
From enrollment to the end of the third month
|
|
Trigger points count
時間枠：From enrollment to the end of the third month
|
Trigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
|
From enrollment to the end of the third month
|
|
Multidimensional quality of life score
時間枠：From enrollment to the end of the third month
|
The multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items.
The overall score is obtained by summing the responses to all the items.
Each item is given a score from 1 to 7, with a total score of 35 to 245.
Higher scores indicate better functional status.
|
From enrollment to the end of the third month
|
|
Likert satisfaction scale
時間枠：From enrollment to the end of the third month
|
Patient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.
|
From enrollment to the end of the third month
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
捜査官
- スタディディレクター：Fatih Baygutalp, Medical doctor、Department of Physical Medicine and Rehabilitation, Ataturk University Faculty of Medicine
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2022年3月15日
一次修了 (実際)
2024年6月30日
研究の完了 (実際)
2025年8月29日
試験登録日
最初に提出
2026年6月30日
QC基準を満たした最初の提出物
2026年6月30日
最初の投稿 (実際)
2026年7月7日
学習記録の更新
投稿された最後の更新 (実際)
2026年7月7日
QC基準を満たした最後の更新が送信されました
2026年6月30日
最終確認日
2026年6月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- B.30.2.ATA.0.01.00/286
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
はい
IPD プランの説明
All the patients' demographic characteristics, including age, sex, educational level, occupation, height and weight
IPD 共有時間枠
Beginning 1 year after publication with no end date
IPD 共有アクセス基準
Access to individual participant data (IPD) and supporting documentation is provided to the principal investigators and the designated research team.
Additionally, access may be granted to journal editors and peer reviewers upon request for the purposes of data verification and manuscript evaluation.
All shared information consists exclusively of de-identified, anonymized raw data to ensure participant privacy.
Access is managed on a request-only basis, ensuring that data is shared securely and in accordance with ethical standards and institutional guidelines.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- ICF
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Cupping therapyの臨床試験
-
Universitätsklinikum Hamburg-EppendorfCytoSorbents, Inc募集
-
Universitätsklinikum Hamburg-Eppendorf完了